PAMIDRONATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Pamidronate, and what generic alternatives are available?
Pamidronate is a drug marketed by Aesgen, Am Regent, Areva Pharms, Dr Reddys, Fresenius Kabi Usa, Hikma, Hospira, Mn Pharms, Mylan Labs Ltd, Sagent Pharms Inc, Sun Pharma Global, and Teva Pharms Usa. and is included in fourteen NDAs.
The generic ingredient in PAMIDRONATE is pamidronate disodium. There are five drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the pamidronate disodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Pamidronate
A generic version of PAMIDRONATE was approved as pamidronate disodium by HIKMA on April 30th, 2001.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PAMIDRONATE?
- What are the global sales for PAMIDRONATE?
- What is Average Wholesale Price for PAMIDRONATE?
Summary for PAMIDRONATE
| US Patents: | 0 |
| Applicants: | 12 |
| NDAs: | 14 |
| DailyMed Link: | PAMIDRONATE at DailyMed |

